Current evidence suggests future protocols may include three stages: Initiation Phase 14 mg weekly 812 week metabolic adaptation Active Weight-Loss Phase 612 mg weekly 612 months Maintenance Phase 36 mg weekly If ongoing trials confirm early findings, retatrutide could become one of the most effective pharmacologic interventions for obesity ever developed
Hexarelin is not approved for human use by the FDA or any regulatory agency
References Kimura H, Takeda K, Tsuruya K et al (2010) Left ventricular mass index is an independent determinant of diastolic dysfunction in patients on chronic hemodialysis: a tissue Doppler imaging study
Over-the-counter antihistamines or topical creams may also help alleviate symptoms
Joseph Dayan: I could speculate, but I really don't know
PubMed record Maquart FX, Bellon G, Chaqour B, et al